pSivida to trade in U.S.

Jan. 27, 2005 — pSivida Limited (ASX: PSD), an Australian nanotechnology company, announced that its U.S. securities registration has been declared effective and it has received preliminary approval from Nasdaq to list shares. It expects to begin trading today under the symbol PSDV.

The American shares will trade on a 10-to-1 ratio to the company’s ordinary shares, which will continue trading on both the Australian and Frankfurt stock exchanges.

The company’s managing director, Gavin Rezos, said in a prepared statement that the Nasdaq listing is part of a broader plan to expand the company’s investor base.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.